Sanofi SA
NASDAQ:SNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
NASDAQ:SNY
|
FR |
|
Aperam SA
OTC:APEMY
|
LU |
|
I
|
Infineon Technologies AG
MIL:IFX
|
DE |
|
A
|
Apollo Investment Corp
F:55O1
|
US |
|
J
|
J B Hunt Transport Services Inc
DUS:JB1
|
US |
|
U
|
UL Solutions Inc
NYSE:ULS
|
US |
|
P
|
Proto Labs Inc
SWB:PRZ
|
US |
|
Sumitomo Electric Industries Ltd
TSE:5802
|
JP |
|
Leonardo SpA
MIL:LDO
|
IT |
|
Illumina Inc
NASDAQ:ILMN
|
US |
Wall St Price Targets
SNY Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNY is 56.15 USD with a low forecast of 33.25 USD and a high forecast of 67.92 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNY's stock price target?
Price Target
56.15
USD
According to Wall Street analysts, the average 1-year price target for SNY is 56.15 USD with a low forecast of 33.25 USD and a high forecast of 67.92 USD.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 5%.
